1. Home
  2. ASYS vs AVIR Comparison

ASYS vs AVIR Comparison

Compare ASYS & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amtech Systems Inc.

ASYS

Amtech Systems Inc.

HOLD

Current Price

$15.83

Market Cap

341.5M

Sector

Technology

ML Signal

HOLD

Logo Atea Pharmaceuticals Inc.

AVIR

Atea Pharmaceuticals Inc.

HOLD

Current Price

$4.80

Market Cap

399.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASYS
AVIR
Founded
1981
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
341.5M
399.3M
IPO Year
2006
2020

Fundamental Metrics

Financial Performance
Metric
ASYS
AVIR
Price
$15.83
$4.80
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$10.00
AVG Volume (30 Days)
385.4K
282.6K
Earning Date
05-07-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
3.00
EPS
0.09
N/A
Revenue
$79,364,000.00
$351,367,000.00
Revenue This Year
$2.82
N/A
Revenue Next Year
$18.75
N/A
P/E Ratio
$176.56
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.30
$2.78
52 Week High
$25.71
$6.45

Technical Indicators

Market Signals
Indicator
ASYS
AVIR
Relative Strength Index (RSI) 38.52 52.35
Support Level $10.84 $4.61
Resistance Level $18.00 $5.04
Average True Range (ATR) 1.18 0.22
MACD -0.17 -0.01
Stochastic Oscillator 2.88 46.25

Price Performance

Historical Comparison
ASYS
AVIR

About ASYS Amtech Systems Inc.

Amtech Systems Inc provides equipment, consumables and services for semiconductor device packaging, wafer production and device fabrication. Its products are used to fabricate and package GPUs for AI applications, SiC and Si power devices, and other optical, analog and digital devices, and are sold to semiconductor packaging, electronic assembly and device fabrication companies. It operates through two segments: Thermal Processing Solutions, which includes conveyorized reflow equipment, high-temperature conveyorized furnaces and diffusion furnaces with maximum revenue; and Semiconductor Fabrication Solutions, which includes consumables, equipment and services for wafer polishing, dicing and cleaning. The majority of revenue is derived from the United States.

About AVIR Atea Pharmaceuticals Inc.

Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.

Share on Social Networks: